tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cencora Settles Stockholder Derivative Action for $111.3M

Story Highlights
  • Cencora agreed to settle a stockholder derivative action related to opioid distribution oversight.
  • The settlement involves a $111.3 million payment by insurers, with no admission of liability.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cencora Settles Stockholder Derivative Action for $111.3M

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Cencora ( (COR) ) has shared an update.

On September 3, 2025, Cencora announced a court-approved agreement to resolve a stockholder derivative action filed by the Lebanon County Employees’ Retirement Fund and Teamsters Local 443 Health Services & Insurance Plan. The complaint, initiated on December 30, 2021, alleged breaches of fiduciary duty related to the oversight of Cencora’s controlled substance diversion control programs. The settlement, reached after a successful mediation, involves insurance carriers paying Cencora $111.3 million, excluding legal fees, without any admission of liability from the defendants. This resolution marks a significant step in addressing claims against the company’s management and could impact its financial standing and stakeholder relations.

The most recent analyst rating on (COR) stock is a Hold with a $306.00 price target. To see the full list of analyst forecasts on Cencora stock, see the COR Stock Forecast page.

Spark’s Take on COR Stock

According to Spark, TipRanks’ AI Analyst, COR is a Neutral.

Cencora’s overall stock score reflects strong earnings performance and raised guidance, which are offset by high leverage and valuation concerns. The technical indicators suggest a neutral market sentiment, while the company’s strategic initiatives provide a positive outlook.

To see Spark’s full report on COR stock, click here.

More about Cencora

Cencora, Inc., formerly known as AmerisourceBergen Corporation, operates in the pharmaceutical distribution industry, focusing on the distribution of controlled substances, including opioids.

Average Trading Volume: 1,261,592

Technical Sentiment Signal: Buy

Current Market Cap: $56.54B

For detailed information about COR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1